To cite this paper use one of the standards below:
Nontuberculous mycobacteria (NTM) are opportunistic pathogens responsible for pulmonary disease in immunocompromised patients or patients with pre-existing lung conditions such as bronchiectasis, cystic fibrosis or chronic obstructive pulmonary disease.1–3 Due to inefficient medicines, the incidence and prevalence of NTM pulmonary disease has increased worldwide.4–6 Based on the crystal structure of compound P218, a dihydrofolate reductase (DHFR) inhibitor developed for malaria,7 bond to Mycobacterium tuberculosis DHFR (tb-DHFR), and docking studies, we decided to design and investigate the activity of macrocyclic analogues against NTM. The key reactions to access the desired compounds are an alkylation reaction to connect the pyrimidine core to linker 2, a Mitsunobu reaction to connect the 2-hydroxyphenyl propanoic core to linker 1, a SN2 reaction to bind the pyrimidine to linker 1, and a Pd/Cu coupling to form the macrocycle with different ring sizes.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper